EQUINOX NEPREMICNINE d.d. Revenue

EQUINOX NEPREMICNINE d.d. had revenue of 2.24M EUR in the quarter ending March 31, 2025, with 37.88% growth. This brings the company's revenue in the last twelve months to 9.29M, up 22.51% year-over-year. In the year 2024, EQUINOX NEPREMICNINE d.d. had annual revenue of 8.67M with 11.36% growth.

Revenue (ttm)

9.29M

Revenue Growth

+22.51%

P/S Ratio

11.54

Revenue / Employee

n/a

Employees

n/a

Market Cap

107.20M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.67M	884.25K	11.36%
Dec 31, 2023	7.79M	442.80K	6.03%
Dec 31, 2022	7.34M	629.52K	9.38%
Dec 31, 2021	6.71M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition